Madison Avenue Partners’s ACELYRIN SLRN Stock Holding History
Bought
Maintained
Sold
Other funds holding SLRN
Madison Avenue Partners's SLRN Position: Q2 2025 in Review
Madison Avenue Partners sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 4,142,640 shares — an estimated $10.2M sold.
Madison Avenue Partners first reported a position in SLRN in Q1 2025 and held it in 1 quarter. The position peaked at $10.2M in Q1 2025. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.
- Madison Avenue Partners reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
- Madison Avenue Partners sold 4,142,640 ACELYRIN shares in Q2 2025, an estimated $10.2M.
- Madison Avenue Partners first reported a position in ACELYRIN in Q1 2025 and held it in 1 quarter.
- Madison Avenue Partners's ACELYRIN position peaked at $10.2M in Q1 2025.
- 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.
Based on Madison Avenue Partners's 13F filing for Q2 2025, filed 14 Aug 2025.